Veristat, a scientific-minded global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years' experience in clinical trial planning and execution, Veristat is equipped to support any development program. Our team has prepared nearly 100 marketing applications for approval with global regulatory authorities in the last ten years.
Veristat's focus on novel drug development has led to success when handling the unknowns that arise across complicated therapeutic areas, such as rare/ultra-rare disease, cell and gene therapies, oncology, and infectious disease trials. We apply this knowledge base every day to solve any clinical program's challenges, from the simplest to the complex. Veristat has assembled an extraordinary team of experts worldwide who have mastered therapeutic development intricacies, enabling sponsors to succeed in extending and saving lives.
Location: Canada, Montreal (06), Montreal
Employees: 501-1000
Phone: +1 508-429-7340
Founded date: 1994
Investors 3
Mentions in press and media 2
| Date | Title | Description | Source |
| 10.03.2021 | How to Better Plan Your Virtual Trial – A Review of Lessons ... | With multiple virtual trials running right now, the company has designed a customized virtual/hybrid... | prweb.com/... |
| 22.01.2013 | Veristat Secures Growth Capital | HOLLISTON, MA, Leading Clinical Research Organization (CRO) announced today that Variance Developm... | vcnewsdail... |